
The National Institute for Health and Clinical Excellence (NICE) has published final guidance on the use of Entecavir and Telbivudine for the treatment of chronic hepatitis B. NICE produced these two pieces of guidance as part of its rapid single technology appraisal (STA) work programme.
Click here for full Story http://www.medicalnewstoday.com/articles/119493.php |